Alto Capital's Tony Locantro touches on Mako Gold Ltd (ASX:MKG)'s quarterly report which was out this morning as well as recent news from Alta Zinc Ltd (ASX:AZI) which has received funding support for an innovative remote sensing and laser project through the EIT Raw Materials program at its Gorno Zinc Project in northern Italy. Locantro also offers up his thoughts on an update from Chimeric Therapeutics Ltd (ASX:CHM) which has licensed a novel cancer therapy for solid tumours from a world-renowned cell therapy centre.
Tony Locantro says Mako Gold well cashed-up and delivering consistent results
